Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Postoperative Complications in Major Surgery (SURGCOM)

27. maj 2026 opdateret af: Norton Perez-Gutierrez, MD, Hospital Departamental de Villavicencio

Prediction of Postoperative Complications in Major Surgery: A Prospective, Multicenter, Cohort Study in Low- and Middle-income Settings

The primary objective of this study is to develop and validate a multivariable risk prediction model for 30-day major postoperative complications and mortality in patients undergoing major surgery across participating international centers. Despite advancements in perioperative care, surgical complications remain a leading cause of global morbidity and preventable death, particularly in resource-limited or low- and middle-income country (LMIC) settings.

This study utilizes a prospective, multicenter, international cohort design. Data will be collected on patient-level risk factors (e.g., age, frailty, comorbidities), hospital-level infrastructure (e.g., nurse-to-patient ratios, rescue capacity), and perioperative safety processes (e.g., adherence to the WHO Surgical Safety Checklist). Patients will be followed prospectively for up to 30 days post-surgery. The collected data will be used to construct robust predictive models to identify individual patient risk and uncover actionable system-level factors to optimize surgical safety globally.

Studieoversigt

Status

Ikke rekrutterer endnu

Betingelser

Detaljeret beskrivelse

Background and Rationale: Postoperative complications impose a substantial clinical and economic burden worldwide. While extensive research has focused on patient-derived clinical risks, fewer prospective international studies have mathematically integrated hospital structural capabilities and perioperative safety processes into multi-level predictive frameworks. This protocol describes an international, prospective, multicenter cohort study designed to build and validate a predictive model for adverse surgical outcomes. Study Design and Population: This is a multicenter, prospective cohort study. Participating centers will recruit consecutive adult or pediatric patients undergoing major elective or emergency non-cardiac surgery. Major surgery is defined internationally as any procedure requiring general or neuraxial anesthesia with an anticipated duration > 90 minutes, estimated blood loss > 500 mL, or requiring routine postoperative intensive care admission. Patients undergoing minor procedures or those unable to provide informed consent will be excluded. Data Collection and Covariates: Standardized electronic case report forms (eCRFs) will be used to collect data across three main tiers: 1. Patient-level Predictors: Demographics, insurance coverage, American Society of Anesthesiologists (ASA) physical status, Charlson Comorbidity Index, and frailty (measured via the Modified Frailty Index, mFI-5). 2. Procedure: code of surgery. 3. Type of surgery: Emergency/elective surgery, Ambulatory/hospitalized, severity, specialty. Outcomes and Follow-up: All participants will be systematically tracked during their inpatient stay, with mandatory clinical follow-up at postoperative day 30 (via medical record review). Primary Outcome: Composite incidence of major 30-day postoperative complications, graded according to the Clavien-Dindo classification (Grade > III, indicating complications requiring surgical, endoscopic, or radiological intervention, life-threatening complications, or death). Secondary Outcomes: 30-day all-cause mortality, individual complication rates (surgical site infections, major bleeding, thromboembolic events, organ failure), hospital length of stay, and "Failure to Rescue" rates (proportion of patients who die after developing a major complication). Statistical Analysis and Predictive Modeling: Sample size calculations are based on the Events Per Variable (EPV) criterion, ensuring a minimum of 15-20 events per candidate predictor in the multivariable model to prevent overfitting. Multilevel multivariable logistic regression and mixed-effects Cox proportional hazards models will be constructed, treating the hospital/country of origin as a random effect to account for institutional clustering. Model performance will be rigorously evaluated. Discriminatory capacity will be assessed using the area under the receiver operating characteristic curve (AUROC). Calibration will be assessed via calibration curves (observed vs. predicted risk). Sensitivity analyses will compare traditional regression models. Reporting will adhere strictly to TRIPOD and STROBE guidelines.

Undersøgelsestype

Observationel

Tilmelding (Anslået)

364

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Studiesteder

    • Meta Department
      • Villavicencio, Meta Department, Colombia, 50001
        • Hospital Departamental de Villavicencio
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Norton Perez-Gutiérrez, MD

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Barn
  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ingen

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

Patients included in the study are those with a major operative procedure during a window opportunity of 7 days.

Beskrivelse

Inclusion Criteria:

  • Major surgery
  • Adult or pediatric patients
  • Emergency or elective surgery
  • Ambulatory or hospitalized patients

Exclusion Criteria:

  • Patients derived to other institution

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Kohorter og interventioner

Gruppe / kohorte
Intervention / Behandling
Complications
Patients with postoperative complications
Patients with observed complications (Clavien-Dindo >3)
No complications
Patients with no postoperative complications

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Combined complications
Tidsramme: 30 days
Postoperative complications by Clavien-Dindo classification > 3
30 days

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Mortality
Tidsramme: 30 days
Patients with postoperative mortality before discharge or within 30 days.
30 days
Surgical site infection
Tidsramme: 30 days
Surgical site infection according to clinical charts
30 days

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Norton Perez-Gutiérrez, MD, Hospital Departamental de Villavicencio

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Generelle publikationer

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

1. august 2026

Primær færdiggørelse (Anslået)

31. juli 2027

Studieafslutning (Anslået)

30. august 2027

Datoer for studieregistrering

Først indsendt

27. maj 2026

Først indsendt, der opfyldte QC-kriterier

27. maj 2026

Først opslået (Faktiske)

2. juni 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

2. juni 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

27. maj 2026

Sidst verificeret

1. maj 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • GRIVI_2026_01_QX_COMPLIC

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

IPD-planbeskrivelse

Patient information involved.

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner